Opportunity for Leadership in Predictive Biomarker Diagnostics for Pre-EclampsiaMetabolomic Diagnostics (“MetaDx”; www.metabolomicdiagnostics.com) is a Cork, Ireland-based predictive biomarker diagnostics company with...
Sage Advises Vesselon on Partnering Its Microbubble Technology for Improving Delivery of Cancer DrugSage has been appointed by Vesselon based in Norwalk Connecticut USA. Vesselon uses patents from Columbia University on the use of...
Sage Represents Mateon Therapeutics - Leadership in Novel Vascular Targeted TherapySage is representing Mateon Therapeutics, a US-based biopharma company focusing on Vascular Disrupting Agents (VDAs) for orphan oncology...
Opportunity to License or Acquire ES-3000, An Orphan Drug for CML and AMLEscend Therapeutics (www.escendpharma.com) is based in San Diego, CA, and develops small molecule therapeutics for oncology orphan drug...